Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Inflammation 1Fatigue 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Early Intervention, Educational 30Educational Status 29Blood Specimen Collection 28Standard of Care 27Methods 25Exercise 20Magnetic Resonance Spectroscopy 19Radiosurgery 18Practice Guidelines as Topic 18Surveys and Questionnaires 17X-Rays 16Tomography, X-Ray Computed 13Radiotherapy 11Interviews as Topic 11Biopsy 11Specimen Handling 10Fluorodeoxyglucose F18 10Patient Navigation 9Bronchoscopy 9Thoracic Surgery, Video-Assisted 8Therapeutics 8Saline Solution 7Psychiatric Rehabilitation 7Palliative Care 7Control Groups 7Breathing Exercises 7Acupuncture Therapy 7Drug Therapy 6Cryosurgery 6Counseling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lung Neoplasms × Chromatin Immunoprecipitation Sequencing × Clear all
NCT07291414 2026-01-21

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

University of Michigan Rogel Cancer Center

Phase NA Recruiting
80 enrolled
BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡